Clinical Trials
25 trialsWSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)
WestVac Biopharma Co., Ltd.
RIOT 4B
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
(RIOT 4A)
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
RIOT2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Jemincare
A Study of MT027 in Patients with Pleural Malignant Tumors
Suzhou Maximum Bio-tech Co., Ltd.
OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.
Odense University Hospital
IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
Affiliated Hospital of Jiangnan University
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
National Institutes of Health Clinical Center (CC)
MpeTK01
Candel Therapeutics, Inc.
A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Jemincare
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
Sichuan Clover Biopharmaceuticals, Inc.
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
Clover Biopharmaceuticals, Ltd
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Comparison of the Effectiveness of Povidone-Iodine Alone to Povidone-Iodine-Tetracycline Combination
University College Hospital, Ibadan
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
PDT-lipo
Centre Hospitalier Universitaire Vaudois
BEVAP
Institut Curie
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
National Cancer Institute (NCI)
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
National Cancer Institute (NCI)